CYCN Financials: Cyclerion Therapeutics Inc AI Analysis



Financials

CYCN Financial

Cyclerion Therapeutics Inc

$3.18

0.63%

$0.02

At close: May 22, 16:00:00 GMT-4

$3.13

-1.57%

$-0.05

Post-market: May 22, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$3.16

Open

$3.15

Day's Range

$3.13 - $3.35

52 week range

$1.02 - $8.48

Volume

35.9K

Avg.Volume

4.2M

Dividend yield

EPS (TTM)

-1.18

Market Cap

$13.5M

What is CYCN?

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 1 full-time employees. The company went IPO on 2019-03-18. The firm is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. The company is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The firm has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.

Features

Markets

News

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	2	1	0	0	0	1
Revenue Growth (YoY)	0%	0%	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	6	1	1	1	1	1
Research & Development	0	0	0	0	0	0
Operating Expenses	7	1	1	1	1	1
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-3	0	0	0	-1	0
Income Tax Expense	--	--	--	--	--	0
Net Income	-3	0	0	0	-1	0
Net Income Growth	200%	--	--	-100%	--	-100%
Shares Outstanding (Diluted)	3.81	3.81	3.22	3.07	2.55	2.54
Shares Change (YoY)	50%	50%	28%	22%	--	4%
EPS (Diluted)	-0.92	-0.2	-0.3	-0.1	-0.55	0.2
EPS Growth	52%	-200.99%	6%	-80%	--	-130%
Free Cash Flow	-3	-1	0	0	0	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-200%	0%	0%	0%	0%	0%
Profit Margin	-150%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-150%	-100%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-4	0	-1	-1	-1	0
EBIT Margin	-200%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	0%

Breakdown

TTM

12/31/2025

09/30/2025

06/30/2025

03/31/2025

12/31/2024

Revenue

Revenue Growth (YoY)

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

Pretax Income

-3

-1

Income Tax Expense

Net Income

-3

-1

Net Income Growth

200%

-100%

Shares Outstanding (Diluted)

3.81

3.22

3.07

2.55

2.54

Shares Change (YoY)

50%

28%

22%

EPS (Diluted)

-0.92

-0.2

-0.3

-0.1

-0.55

0.2

EPS Growth

52%

-200.99%

-80%

-130%

Free Cash Flow

-3

-1

Free Cash Flow Per Share

Gross Margin

Operating Margin

-200%

Profit Margin

-150%

Free Cash Flow Margin

-150%

-100%

EBITDA

EBITDA Margin

D&A For EBITDA

EBIT

-4

-1

EBIT Margin

-200%

Effective Tax Rate

Follow-Up Questions

What are Cyclerion Therapeutics Inc's key financial statements?



According to the latest financial statement (Form-10K), Cyclerion Therapeutics Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for CYCN?



Cyclerion Therapeutics Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Cyclerion Therapeutics Inc's revenue broken down by segment or geography?



Cyclerion Therapeutics Inc largest revenue segment is Novel Therapeutic, at a revenue of 2,073,999 in the most earnings release.For geography, United States is the primary market for Cyclerion Therapeutics Inc, at a revenue of 2,073,999.

Is Cyclerion Therapeutics Inc profitable?



no, according to the latest financial statements, Cyclerion Therapeutics Inc has a net loss of $0

Does Cyclerion Therapeutics Inc have any liabilities?



no, Cyclerion Therapeutics Inc has liability of 0

How many outstanding shares for Cyclerion Therapeutics Inc?



Cyclerion Therapeutics Inc has a total outstanding shares of 0

Cyclerion Therapeutics Inc (CYCN) Financial

CYCN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CYCN?

Cyclerion Therapeutics Inc (CYCN) Financial

CYCN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CYCN?

CYCN Income

Follow-Up Questions

What are Cyclerion Therapeutics Inc's key financial statements?

What are the key financial ratios for CYCN?

How is Cyclerion Therapeutics Inc's revenue broken down by segment or geography?

Is Cyclerion Therapeutics Inc profitable?

Does Cyclerion Therapeutics Inc have any liabilities?

How many outstanding shares for Cyclerion Therapeutics Inc?